Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice

Am J Med. 2017 Dec;130(12):1342-1344. doi: 10.1016/j.amjmed.2017.07.012. Epub 2017 Jul 27.

Authors

Ann M Moyer¹, Carolyn R Rohrer Vitek², Jyothsna Giri², Pedro J Caraballo³

Affiliations

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn. Electronic address: moyer.ann@mayo.edu.
² Center for Individualized Medicine, Mayo Clinic, Rochester, Minn.
³ Department of Medicine, Mayo Clinic, Rochester, Minn.

PMID: 28757317
DOI: 10.1016/j.amjmed.2017.07.012

No abstract available

Keywords: Clinical practice; Genetic testing; Pharmacogenomics; Precision medicine; Standardization; Test selection.

Publication types

Editorial

MeSH terms

Cytochrome P-450 CYP2C19 / genetics
Cytochrome P-450 CYP2D6 / genetics
Humans
Laboratories*
Patient Care / methods
Pharmacogenetics / economics
Pharmacogenetics / methods*
Pharmacogenomic Testing*
Precision Medicine / economics
Precision Medicine / methods
United States

Substances

Cytochrome P-450 CYP2C19
Cytochrome P-450 CYP2D6